問題詳情

59.下列有關 carvedilol 之敘述,何者錯誤何者錯誤?
(A)屬於混合型α/β受體阻斷劑
(B)S(-)-異構物主要具β-受體拮抗作用
(C)去甲基代謝物不具作用活性
(D)可治療心衰竭

參考答案

答案:C
難度:適中0.578
書單:沒有書單,新增

用户評論

Celeste】評論

ANonselective beta-adrenergic and alpha1-adrenergic blocking agent with no intrinsic activity for use in congestive heart failure and hypertensionBCarvedilol is administered as its racemate. Its S(-)-enantiomer is both an a- and nonselective B blocker, whereas its R(+)-enantiomer is an a-blocker.CCarvedilol is extensively metabolized; phenol ringdemethylation and hydroxylation produce 3 metabolites with beta adrenergic blocking activity and (weak) vasodilating activity. Plasma concentrations of active metabolites are about 10% those of carvedilol. The 4' hydroxyphenyl metabolite is 13 times more potent than carvedilol in beta-adrenergic blocking activity.DCongestive Heart Failure, Hypertension